poisar

Stocks · News reference

Mizuho Adjusts Price Target on Belite Bio to $230 From $221, Maintains Outperform Rating

Fiscal.ai

Mizuho Securities has updated its price target for Belite Bio, increasing it to $230 from the previous $221 while maintaining an Outperform rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading